Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.280
-0.030 (-0.91%)
At close: Feb 18, 2026, 4:00 PM EST
3.340
+0.060 (1.83%)
After-hours: Feb 18, 2026, 5:20 PM EST

Exagen Revenue

Exagen had revenue of $17.24M in the quarter ending September 30, 2025, with 37.87% growth. This brings the company's revenue in the last twelve months to $63.60M, up 14.08% year-over-year. In the year 2024, Exagen had annual revenue of $55.64M with 5.89% growth.

Revenue (ttm)
$63.60M
Revenue Growth
+14.08%
P/S Ratio
1.17
Revenue / Employee
$295,809
Employees
215
Market Cap
74.33M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202455.64M3.09M5.89%
Dec 31, 202352.55M6.99M15.33%
Dec 31, 202245.56M-2.74M-5.66%
Dec 31, 202148.30M6.32M15.07%
Dec 31, 202041.98M1.59M3.93%
Dec 31, 201940.39M7.95M24.50%
Dec 31, 201832.44M5.63M21.01%
Dec 31, 201726.81M8.86M49.38%
Dec 31, 201517.95M6.28M53.87%
Dec 31, 201411.66M8.61M281.77%
Dec 31, 20133.06M2.13M229.91%
Dec 31, 2012926.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics825.30M
Inotiv514.03M
Fulgent Genetics315.55M
FONAR106.03M
MDxHealth103.07M
Prenetics Global92.39M
Biodesix80.17M
Burning Rock Biotech75.75M
Revenue Rankings